Phase III trial completed by Bharat Biotech for Nasal Vaccine

Phase III trial completed by Bharat Biotech for Nasal Vaccine

The clinical phase III trials of the Covid-19 nasal vaccination have been finished, according to Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, who stated the company will submit its data to the Drugs Controller General of India (DCGI) next month. Ella remarked, “We recently concluded a clinical experiment and are currently analysing…

Covid-19 vaccination

Covid-19 vaccination coverage in India crosses 165.6 crore as per Health Ministry

COVID-19 vaccination coverage in India has crossed almost 165.6 crore with over 53 lakh vaccine doses administered this Saturday, as per a recent report by the Union health ministry. The regular vaccination tally is expected to double up with the compilation of the final reports, as per recent statement. Approximately, 53,96,51,188 first doses have been…